LaKind Associates, LLC

Josh Naiman

Josh Naiman, Naiman Consulting, LLC

Josh Naiman is a consultant with research experience in environmental exposure and systematic review. His previous work includes a systematic analysis of human exposure to the pesticide 2,4-D, and an evaluation of governmental cancer cluster investigations. Josh has a B.A. in neuroscience from the University of Pennsylvania.

Publications

  • Nakayama SF, St- Amand A, Pollock T, Ashley - Martin J, Bamai YA, Barr DB, Bessems J, Calafat A, Castaño A, Covaci A, Duca RC, Faure S, Galea KS, Hays S, Hopf NB, Ito Y, Jeddi MZ, Kolossa - Gehring M, Kumar E, LaKind JS, López ME, Louro H, Makris KC, Melnyk L, Naiman J, Nassif J, Noisel N, Quirós - Alcalá L, Rafiee A, Rambaud L, Silva MJ, Ueyama J, Verner M - A, Waras MN, Werry K. 2023. Interpreting biomonitoring data: Introducing the i - HBM Working Group’s Guidance Value Dashboard.International Journal of Hygiene and Environmental Health. 247: 114046.

    View Paper Here

  • LaKind JS, Naiman J, Verner M-A, Lévêque L, Fenton S. 2023. Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: A global issue. Environmental Research 219:115042.

    View Paper Here

  • Burns CJ, LaKind JS, Naiman J, Boon D, Clougherty JE, Rule AM, Zidek A. Research on COVID-19 and air pollution: A path towards advancing the science. Environmental Research 212, Part A:113240.

    View Paper Here

  • LaKind JS, Naiman J, Burns CJ. Translation of exposure and epidemiology for risk assessment: A shifting paradigm. 2020. International Journal of Environmental Research and Public Health 17(12):4220.

    View Paper Here

  • LaKind JS, Burns CJ, Naiman DQ, O’Mahony C, Vilone G, Burns AJ, Naiman JS. 2017. Critical and systematic evaluation of data for estimating human exposures to 2,4-dichlorophenoxyacetic acid (2,4-D) – quality and generalizability. Journal of Toxicology and Environmental Health, Part B. 20(8):423-446.

    View Paper Here

  • Goodman M, Naiman JS, Goodman D, LaKind JS. 2013. Response to Condon et al. comments on “Cancer clusters in the USA: What do the last twenty years of state and federal investigations tell us?” Critical Reviews in Toxicology 43(1)75–76.

    View Paper Here